Work

Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. A Review of FDA Guidance

Year: 2010
Type: review
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2185855791
FWCI: 0.037
Cites: 10
Cited by: 1
Related to: 10